Publication: Review of methods and antimicrobial agents for susceptibility testing against Pythium insidiosum
Issued Date
2020-04-01
Resource Type
ISSN
24058440
Other identifier(s)
2-s2.0-85083007332
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Heliyon. Vol.6, No.4 (2020)
Suggested Citation
Hanna Yolanda, Theerapong Krajaejun Review of methods and antimicrobial agents for susceptibility testing against Pythium insidiosum. Heliyon. Vol.6, No.4 (2020). doi:10.1016/j.heliyon.2020.e03737 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/54723
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Review of methods and antimicrobial agents for susceptibility testing against Pythium insidiosum
Author(s)
Abstract
© 2020 The Author(s) Pythiosis is a life-threatening infectious disease of humans and animals caused by the oomycete microorganism Pythium insidiosum. The disease has been increasingly diagnosed worldwide. P. insidiosum inhabits freshwater and presents in two forms: mycelium and zoospore. Clinical manifestations of pythiosis include an infection of the artery, eye, skin, or gastrointestinal tract. The management of pythiosis is problematic due to the lack of effective treatment. Many patients die from an uncontrolled infection. The drug susceptibility testing provides clinically-useful information that could lead to proper drug selection against P. insidiosum. Currently, no standard CLSI protocol for the drug susceptibility of P. insidiosum is available. This review aims at describing methods and antimicrobial agents for susceptibility testing against P. insidiosum. Several in-house in vitro susceptibility methods (i.e., broth microdilution method, radial growth method, and agar diffusion method) have been established for P. insidiosum. Either mycelium or zoospore can be an inoculum. Rabbit is the commonly-used model of pythiosis for in vivo drug susceptibility testing. Based on the susceptibility results (i.e., minimal inhibitory concentration and inhibition zone), several antibacterial and antifungal drugs, alone or combination, exhibited an in vitro or in vivo effect against P. insidiosum. Some distinct compounds, antiseptic agents, essential oils, and plant extracts, also show anti-P. insidiosum activities. Successfully medical treatment, guided by the drug susceptibility data, has been reported in some pythiosis patients. Future studies should emphasize finding a novel and effective anti-P. insidiosum drug, standardizing in vitro susceptibility method and correlating drug susceptibility data and clinical outcome of pythiosis patients for a better interpretation of the susceptibility results.